| Dr Anuradha Puri Dua, MD | |
|
8101 Hinson Farm Rd, Suite 219, Alexandria, VA 22306 | |
| (703) 360-8383 | |
| (703) 360-0263 |
| Full Name | Dr Anuradha Puri Dua |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 32 Years |
| Location | 8101 Hinson Farm Rd, Alexandria, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528079241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 0101057825 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Mount Vernon Hospital | Alexandria, VA | Hospital |
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Llc | 4385682061 | 1176 |
News Archive
Patients with glioblastoma, a type of malignant brain tumor, usually survive fewer than 15 months following diagnosis. Since there are no effective treatments for the deadly disease, University of California, San Diego researchers developed a new computational strategy to search for molecules that could be developed into glioblastoma drugs. In mouse models of human glioblastoma, one molecule they found shrank the average tumor size by half.
Abbott today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study for ISIS-APOARx, an antisense drug targeting apolipoprotein(a) for the treatment of atherosclerosis.
To advocate for the passage of AB 1598 – Authored by Assembly Member Jim Beall (D-San Jose), the measure will prohibit the import, production, manufacture, distribution, or sale of caffeinated malt beverages (Alcoholic Energy Drinks – AEDs) in California.
› Verified 7 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298 |
News Archive
Patients with glioblastoma, a type of malignant brain tumor, usually survive fewer than 15 months following diagnosis. Since there are no effective treatments for the deadly disease, University of California, San Diego researchers developed a new computational strategy to search for molecules that could be developed into glioblastoma drugs. In mouse models of human glioblastoma, one molecule they found shrank the average tumor size by half.
Abbott today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study for ISIS-APOARx, an antisense drug targeting apolipoprotein(a) for the treatment of atherosclerosis.
To advocate for the passage of AB 1598 – Authored by Assembly Member Jim Beall (D-San Jose), the measure will prohibit the import, production, manufacture, distribution, or sale of caffeinated malt beverages (Alcoholic Energy Drinks – AEDs) in California.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anuradha Puri Dua, MD 11357 Sunset Hills Rd, Reston, VA 20190 Ph: (703) 435-5858 | Dr Anuradha Puri Dua, MD 8101 Hinson Farm Rd, Suite 219, Alexandria, VA 22306 Ph: (703) 360-8383 |
News Archive
Patients with glioblastoma, a type of malignant brain tumor, usually survive fewer than 15 months following diagnosis. Since there are no effective treatments for the deadly disease, University of California, San Diego researchers developed a new computational strategy to search for molecules that could be developed into glioblastoma drugs. In mouse models of human glioblastoma, one molecule they found shrank the average tumor size by half.
Abbott today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study for ISIS-APOARx, an antisense drug targeting apolipoprotein(a) for the treatment of atherosclerosis.
To advocate for the passage of AB 1598 – Authored by Assembly Member Jim Beall (D-San Jose), the measure will prohibit the import, production, manufacture, distribution, or sale of caffeinated malt beverages (Alcoholic Energy Drinks – AEDs) in California.
› Verified 7 days ago
George Peter Silis, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5115 Franconia Road, Sutie G, Alexandria, VA 22310 Phone: 703-922-4222 Fax: 703-922-4253 | |
Dr. Madhusudanan Srambickal Ramaswamy, M.D., M.S. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4320 Seminary Rd, Alexandria, VA 22304 Phone: 703-504-3000 Fax: 571-285-0027 | |
Nabeela Tabassum, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 4810 Beauregard St, Ste 303, Alexandria, VA 22312 Phone: 703-750-0108 Fax: 703-750-0230 | |
Dr. Chinedu Madu, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4825 Mark Center Dr Ste 150, Alexandria, VA 22311 Phone: 703-751-8111 Fax: 703-751-1105 | |
Kim-dung T Nguyen, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5130 Duke St, 8, Alexandria, VA 22304 Phone: 703-823-2849 Fax: 703-823-2847 | |
Dr. Muhammed F. Khokhar, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave Ste 810, Alexandria, VA 22304 Phone: 703-823-0333 Fax: 703-823-8611 | |
Tariq Rehman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4141a Duke St, Alexandria, VA 22304 Phone: 703-461-3556 Fax: 703-461-8075 |